Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Myeloma Crowd, now operating as HealthTree for Multiple Myeloma under the HealthTree Foundation, is a patient-driven non-profit organization focused on accelerating a cure for multiple myeloma. Founded in 2012 by patient advocate Jenny Ahlstrom, the organization provides a comprehensive ecosystem of support, including patient education, advocacy, and a sophisticated data-driven research platform. Its flagship technology, the HealthTree Cure Hub, enables patients to manage their medical records while contributing de-identified data to a global database used by researchers to identify patterns and optimize treatments. The foundation also directly funds innovative clinical research through the Myeloma Crowd Research Initiative (MCRI), specifically targeting high-risk and relapsed disease. By empowering patients with information and tools, HealthTree aims to bridge the gap between clinical care and breakthrough research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Myeloma Crowd.